All eye drop users should check out the FDA's list of 26 different eye drops that could cause infection or even blindness. The FDA has reported that Velocity Pharma manufactured its eye drops under ...

HONG KONG SAR – EQS Newswire – 21 May 2025 – Uni-Bio Science Group Limited (the “Company”, together with its subsidiaries, the “Group”) proudly announces that its new ophthalmology product, 金因康 ® ...

“Tryptyr is the first eye drop that stimulates corneal nerves to directly address tear deficiency, a known cause of dry eye disease." Approval of Tryptyr was granted to Alcon. Alcon anticipates ...

MONDAY, June 2, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved the first-in-class TRPM8 receptor agonist Tryptyr (acoltremon ophthalmic solution) for the treatment of ...

“Tryptyr is the first eye drop that stimulates corneal nerves to directly address tear deficiency, a known cause of dry eye disease." Approval of Tryptyr was granted to Alcon.

The ophthalmic solution will be available in single-dose vials with a recommended dosage of one drop in each eye twice a day. Approval of Tryptyr was based on the results of two phase 3 clinical ...

The ophthalmic solution will be available in single-dose vials with a recommended dosage of one drop in each eye twice a day.

Elon Musk was spotted with a black spot near his eye during President Donald Trump's press conference at the Oval Office on Friday. This comes hours after a New York Times report made explosive ...

Using eye drops incorrectly — for instance, applying two or more types too close together — may also increase dry eye risk. If your doctor prescribes eye drops, be sure to follow the ...

Six years after being spun out from Novartis and becoming a public company, eye care specialist Alcon has gained its ... which is administered as a single drop twice daily, is a first-in-class ...

The exact mechanism of action for TRYPTYR in DED is unknown. TRYPTYR is available in easy-to-use, single dose vials: one drop per eye, two times a day. 3 Alcon expects to launch TRYPTYR in the U.S. in ...

Alcon Inc. (NYSE:ALC) has announced that the U.S. Food and Drug Administration (FDA) has approved TRYPTYR (acoltremon ophthalmic solution) 0.003% for the treatment of signs and symptoms of Dry Eye ...